Transatlantique Private Wealth LLC Bristol Myers Squibb CO Transaction History
Transatlantique Private Wealth LLC
- $253 Million
- Q3 2024
A detailed history of Transatlantique Private Wealth LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Transatlantique Private Wealth LLC holds 14,732 shares of BMY stock, worth $840,313. This represents 0.3% of its overall portfolio holdings.
Number of Shares
14,732
Previous 19,396
24.05%
Holding current value
$840,313
Previous $805,000
5.34%
% of portfolio
0.3%
Previous 0.33%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,553Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.05 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.3 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.45 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.48 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $121B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...